SEC Form 4 · accession 0001127602-18-009997

CONMED Corp · CNMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP GM Advanced Surgery

Period of report

Mar 1, 2018

Accepted (ET)

Mar 5, 2018 · 3:43 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000816956

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 1, 2018	M	425	$0.00	A	2,796	D
Common Stock	Mar 1, 2018	F	127	$59.96	D	2,669	D
Common Stock	Mar 1, 2018	M	400	$0.00	A	3,069	D
Common Stock	Mar 1, 2018	F	119	$59.96	D	2,950	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Rsus (restricted Stock Units)^F1	$0.00	Mar 1, 2018	M	425	D	—	Mar 1, 2026	Common Stock	425	850	D
Rsus (restricted Stock Units)^F2	$0.00	Mar 1, 2018	M	400	D	—	Feb 27, 2025	Common Stock	400	400	D
Options To Purchase Common Stock^F3	$59.96	Mar 1, 2018	A	32,000	A	—	Mar 1, 2028	Common Stock	32,000	32,000	D

F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F3The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period